[Therapeutic study of Daktacort in dermatological disorders (author's transl)].
The activity of Daktacort was studied in various types of mycotis skin ailments. A total of 40 cases were treated and results were very good in 34 cases and insufficient or nil in 6 cases. Tolerance was excellent.
D000287:Administration, Topical; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy*; D004338:Drug Combinations; D006801:Humans; D006854:Hydrocortisone; D007093:Imidazoles / Q000627:therapeutic use*; D008825:Miconazole / Q000009:adverse effects / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D003879:Dermatologic Agents; D004338:Drug Combinations; D007093:Imidazoles; C024105:Daktacort; D008825:Miconazole; D006854:Hydrocortisone
Contribution à l'étude du Daktacort en dermatologie.